Riskpilot← Back to searchSign inGet full accessALPINE BIOMED ApS
APSDissolvedCVR 30277260Hørskætten 9Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20076 employees
Revenue 2018
DKK 7M
-12% vs 2017
EBITDA margin
33.2%
+267% vs 2017
Equity ratio
22.3%
Financial strength
Net profit 2018
DKK -21,4M
-137% vs 2017
| Revenue | DKK 7M | -12% |
| EBITDA | DKK 2,3M | +267% |
| Net profit | DKK -21,4M | -137% |
| Total assets | DKK 721,9M | -3% |
| Equity | DKK 160,8M | -12% |
| Employees | 6 | — |
Legal name
ALPINE BIOMED ApS
CVR number
30277260
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
13. februar 2007
Share capital
DKK 1.000.000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2018-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Address
Hørskætten 9
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 39.066 | 30.346 | 17.845 | 23.646 | 8.016 | 7.045 |
| Staff expenses | -19.324 | -16.883 | -9.594 | -7.985 | -9.416 | -4.703 |
| EBITDA | 13.876 | 343 | 28 | 15.662 | -1.400 | 2.342 |
| Depreciation & amort. | -2.540 | -1.701 | -844 | -758 | -434 | -12 |
| EBIT | 11.336 | -1.358 | -815 | 14.903 | -1.834 | 2.330 |
| Net financials | 1.377 | -1.424 | -41 | -530 | 76.707 | -29.817 |
| Profit before tax | 12.713 | -2.781 | -857 | 14.374 | 74.873 | -27.487 |
| Tax | 4.216 | -694 | -0 | 3.376 | 16.529 | -6.101 |
| Net profit | 8.498 | -2.088 | -856 | 10.998 | 58.344 | -21.386 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|---|---|
| Total assets | 89.469 | 92.742 | 99.362 | 764.047 | 746.138 | 721.862 |
| Equity | 54.075 | 53.022 | 52.165 | 60.548 | 182.229 | 160.843 |
| Long-term debt | 15.654 | 0 | 0 | 682.730 | 534.259 | 536.620 |
| Short-term debt | 7.169 | 39.721 | 47.197 | 20.769 | 13.764 | 18.251 |
| Total debt | 22.823 | 39.721 | 47.197 | 703.498 | 548.023 | 554.871 |
EBITDA margin
33.2%
This company
15.8%
Market median
+110% vs market
20132018
Equity ratio
22.3%
This company
38.2%
Market median
-42% vs market
20132018
Return on equity
-13.3%
This company
18.4%
Market median
-172% vs market
20132018
Net profit margin
-303.6%
This company
8.1%
Market median
-3848% vs market
20132018
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20132018
Debt / equity
3.49×
This company
0.62×
Market median
-463% vs market
20132018
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CB Management | Management | 2010 | — | — |
SD Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
WH Management | Management | 2007 | — | — |
MM Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
BC Management | Management | 2007 | — | — |
BD Management | Management | 2019 | — | — |
KR Chief Executive Officer | Chief Executive Officer | 2007 | — | — |
EJ Chief Executive Officer | Chief Executive Officer | 2009 | — | — |
PA Management | Management | 2007 | — | — |
AF Management | Management | 2019 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ALPINE BIOMED ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carsten Bull | Management | 0 companies |
| Sean David Langan | Chief Executive Officer | 0 companies |
| William Harry Brown | Management | 0 companies |
| Markus Mönkhoff | Chief Executive Officer | 0 companies |
| Bradford Clark Westcott | Management | 0 companies |
| Benjamin Drew Davies | Management | 0 companies |
| Kim Rasmussen | Chief Executive Officer | 0 companies |
| Erik Jensen | Chief Executive Officer | 0 companies |
| Peter Andreas Stakemann | Management | 0 companies |
| Austin Francis Noll | Management | 0 companies |